title: Cytoplasmic initiation of cisplatin cytotoxicity.
abstract: The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies have implicated both nuclear and cytoplasmic causes of cisplatin-induced death in cultured cells. We have demonstrated that cisplatin cytotoxicity depends on cdk2 activity, which is at least partly through the cdk2-E2F1 pathway. The mechanism of the dependency on cdk2, and whether cdk2 activation of E2F1 represents the only cell death pathway involved, is still unclear. Our previous work showed that deletion of the nuclear localization signal from p21 WAF1/CIP1, a cdk2 inhibitor, did not alter its protective action against cisplatin cytotoxicity. Active cdk2-cyclin complexes are localized in both the nucleus and cytoplasm, and it was reported that cdk2 translocated to the cytoplasm after an apoptotic stimulus. Herein, we show that cisplatin caused cell death in enucleated mouse kidney proximal tubule cells (TKPTS), which was prevented by cdk2 inhibition. Also, we localized cytoplasmic cdk2 to both the endoplasmic reticulum (ER) and Golgi compartments, and ER stress was blocked by specific cdk2 inhibition. We conclude that cisplatin can induce nuclear independent apoptosis, cisplatin cytotoxicity can be initiated by cytoplasmic events, and cytoplasmic cdk2 plays an important role in apoptosis signaling.
authors.affiliation: Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors.forename: Fang
authors.initials: F
authors.lastname: Yu
authors.forename: Judit
authors.initials: J
authors.lastname: Megyesi
authors.forename: Peter M
authors.initials: PM
authors.lastname: Price
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D002451:Cell Compartmentation; D002467:Cell Nucleus / Q000502:physiology; D002478:Cells, Cultured; D002945:Cisplatin / Q000633:toxicity*; D051357:Cyclin-Dependent Kinase 2 / Q000037:antagonists & inhibitors / Q000378:metabolism; D003593:Cytoplasm / Q000502:physiology*; D004721:Endoplasmic Reticulum / Q000378:metabolism; D006056:Golgi Apparatus / Q000378:metabolism; D007687:Kidney Tubules, Proximal / Q000166:cytology / Q000187:drug effects*; D051379:Mice; D011993:Recombinant Fusion Proteins / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D011993:Recombinant Fusion Proteins; C495893:Cdk2 protein, mouse; D051357:Cyclin-Dependent Kinase 2; D002945:Cisplatin